NO991460D0 - Anvendelse av 1-hydroksy-2-pyridoner til behandling av seborÚisk dermatitt - Google Patents

Anvendelse av 1-hydroksy-2-pyridoner til behandling av seborÚisk dermatitt

Info

Publication number
NO991460D0
NO991460D0 NO991460A NO991460A NO991460D0 NO 991460 D0 NO991460 D0 NO 991460D0 NO 991460 A NO991460 A NO 991460A NO 991460 A NO991460 A NO 991460A NO 991460 D0 NO991460 D0 NO 991460D0
Authority
NO
Norway
Prior art keywords
pyridones
hydroxy
treatment
seborrheic dermatitis
seborrheic
Prior art date
Application number
NO991460A
Other languages
English (en)
Other versions
NO991460L (no
NO312492B1 (no
Inventor
Manfred Bohn
Karl Theodor Kraemer
Astrid Markus
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of NO991460D0 publication Critical patent/NO991460D0/no
Publication of NO991460L publication Critical patent/NO991460L/no
Publication of NO312492B1 publication Critical patent/NO312492B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/006—Antidandruff preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4412—Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/02—Preparations for cleaning the hair

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Birds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Pyridine Compounds (AREA)
NO19991460A 1996-09-27 1999-03-25 Anvendelse av 1-hydroksy-2-pyridoner til behandling av sebor±isk dermatitt NO312492B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19639818A DE19639818A1 (de) 1996-09-27 1996-09-27 Verwendung von 1-Hydroxy-2-pyridonen zur Behandlung der Seborrhoischen Dermatitis
PCT/EP1997/005070 WO1998013009A2 (de) 1996-09-27 1997-09-16 Verwendung von 1-hydroxy-2-pyridonen zur behandlung der seborrhoischen dermatitis

Publications (3)

Publication Number Publication Date
NO991460D0 true NO991460D0 (no) 1999-03-25
NO991460L NO991460L (no) 1999-03-25
NO312492B1 NO312492B1 (no) 2002-05-21

Family

ID=7807118

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19991460A NO312492B1 (no) 1996-09-27 1999-03-25 Anvendelse av 1-hydroksy-2-pyridoner til behandling av sebor±isk dermatitt

Country Status (32)

Country Link
EP (1) EP0928183B1 (no)
JP (2) JP2001500884A (no)
KR (1) KR100494207B1 (no)
CN (1) CN1104231C (no)
AR (1) AR008860A1 (no)
AT (1) ATE209891T1 (no)
AU (1) AU716208B2 (no)
BG (1) BG64365B1 (no)
BR (1) BR9711575A (no)
CA (1) CA2267165C (no)
CY (1) CY2362B1 (no)
CZ (1) CZ291485B6 (no)
DE (2) DE19639818A1 (no)
DK (1) DK0928183T3 (no)
ES (1) ES2167721T3 (no)
HK (1) HK1022267A1 (no)
HU (1) HU226955B1 (no)
ID (1) ID21874A (no)
IL (1) IL129141A0 (no)
MA (1) MA24333A1 (no)
MY (1) MY125674A (no)
NO (1) NO312492B1 (no)
NZ (1) NZ334850A (no)
OA (1) OA11028A (no)
PL (1) PL188033B1 (no)
PT (1) PT928183E (no)
RS (1) RS49801B (no)
TR (1) TR199900662T2 (no)
TW (1) TW519491B (no)
UA (1) UA57754C2 (no)
WO (1) WO1998013009A2 (no)
ZA (1) ZA978640B (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19639816A1 (de) 1996-09-27 1998-04-02 Hoechst Ag Antimykotische Mittel mit hoher Wirkstofffreisetzung
US20040039030A1 (en) 1996-09-27 2004-02-26 Hoechst Akeengesellschaft Use of 1-hydroxy-2-pyridones for the treatment of seborrheic dermatitis
US20050095215A1 (en) * 2003-11-03 2005-05-05 Popp Karl F. Antimicrobial shampoo compositions
ES2402041T3 (es) 2007-08-31 2013-04-26 Janssen Pharmaceutica, N.V. Combinaciones de imazalil e hidroxipiridonas
CN101877968A (zh) 2007-11-30 2010-11-03 詹森药业有限公司 杀真菌的吡咯化合物和pyrion化合物的组合
CN101932243B (zh) 2008-02-06 2014-04-23 詹森药业有限公司 苯基吡咯和吡啶酮*化合物的组合
EP2587920B1 (en) 2010-07-01 2016-08-10 Janssen Pharmaceutica, N.V. Antimicrobial combinations of pyrion compounds with polyethyleneimines
ES2573116T3 (es) * 2010-12-02 2016-06-06 The University Of Kansas Profármacos de 6-ciclohexil-1-hidroxi-4-metilpiridin-2(1H)-ona y sus derivados
WO2013011996A1 (ja) * 2011-07-19 2013-01-24 リジェンティス株式会社 酵母菌から抽出されたポリリン酸，ポリリン酸の塩又はポリリン酸の溶媒和物を含むポリリン酸組成物及びその製造方法。
FR2983858B1 (fr) * 2011-12-08 2014-01-03 Fabre Pierre Dermo Cosmetique Nouveaux composes inhibiteurs de la lipogenese
CN104744359B (zh) * 2015-03-06 2017-10-10 上药康丽（常州）药业有限公司 一种环吡酮的精制方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2234009C3 (de) * 1972-07-11 1979-01-11 Hoechst Ag, 6000 Frankfurt Kosmetische Zubereitungen
NL8601762A (nl) * 1986-07-07 1988-02-01 Bouke Jan Lange Werkwijze voor de reiniging en conditionering en eventuele medicinale behandeling van het haar en de hoofdhuid, een voor dit doel bruikbare tweefasen shampoo, alsmede een verpakking daarvoor.
CA2143329A1 (en) * 1992-09-08 1994-03-17 Karen K. Kalla Mild, substantially colorless shampoo composition
DE4333893A1 (de) * 1993-10-05 1995-04-06 Hoechst Ag Kosmetische Zubereitungen
FR2722689B1 (fr) * 1994-07-20 1996-10-04 Fabre Pierre Dermo Cosmetique Nouveau produit de combinaison comprenant un agent antifongique et du crotamiton comme potentialisateur de l'activite de l'agent antifongique, et compositions dermatologiques et/ou cosmetiques le comprenant

Also Published As

Publication number Publication date
AU716208B2 (en) 2000-02-24
AU4774697A (en) 1998-04-17
DE59705697D1 (de) 2002-01-17
BG103260A (en) 2000-01-31
MA24333A1 (fr) 1998-04-01
BR9711575A (pt) 1999-08-24
CN1231595A (zh) 1999-10-13
DE19639818A1 (de) 1998-04-02
CY2362B1 (en) 2004-06-04
JP2006176540A (ja) 2006-07-06
EP0928183A2 (de) 1999-07-14
IL129141A0 (en) 2000-02-17
NO991460L (no) 1999-03-25
EP0928183B1 (de) 2001-12-05
PT928183E (pt) 2002-05-31
WO1998013009A3 (de) 1998-05-14
RS49801B (sr) 2008-06-05
BG64365B1 (bg) 2004-12-30
HUP9903811A3 (en) 2001-11-28
KR20000048613A (ko) 2000-07-25
HK1022267A1 (en) 2000-08-04
ATE209891T1 (de) 2001-12-15
PL188033B1 (pl) 2004-11-30
NZ334850A (en) 2001-02-23
TR199900662T2 (xx) 1999-06-21
AR008860A1 (es) 2000-02-23
MY125674A (en) 2006-08-30
CA2267165C (en) 2003-12-16
KR100494207B1 (ko) 2005-06-13
WO1998013009A2 (de) 1998-04-02
JP2001500884A (ja) 2001-01-23
DK0928183T3 (da) 2002-04-02
CZ291485B6 (cs) 2003-03-12
CN1104231C (zh) 2003-04-02
ID21874A (id) 1999-08-05
CA2267165A1 (en) 1998-04-02
OA11028A (fr) 2003-03-06
TW519491B (en) 2003-02-01
UA57754C2 (uk) 2003-07-15
HUP9903811A1 (hu) 2000-04-28
HU226955B1 (en) 2010-03-29
ES2167721T3 (es) 2002-05-16
NO312492B1 (no) 2002-05-21
ZA978640B (en) 1998-03-27
CZ107599A3 (cs) 1999-06-16
PL332603A1 (en) 1999-09-27
YU13499A (sh) 2001-09-28

Similar Documents

Publication Publication Date Title
NO991955D0 (no) FremgangsmÕte for behandling av hydrokarboner
NO983284D0 (no) Antikoagolante midler egnet i behandling av trombose
NO991381D0 (no) Kombinasjonsterapi for behandling av psykoser
NO20005864D0 (no) Quinasoler til behandling av hjernesvulst
NO976063D0 (no) Fremgangsmåte for behandling av diabetes
NO20003042D0 (no) FremgangsmÕte for profylaktisk behandling av mastitt
NO991459D0 (no) Anvendelse av 1-hydroksy-2-pyridoner til behandling av hudinfeksjoner
NO991460L (no) Anvendelse av 1-hydroksy-2-pyridoner til behandling av seborÚisk dermatitt
NO20010456L (no) Triazolopyridiner for behandling av trombose lidelser
NO984432D0 (no) FremgangsmÕte for behandling av migrenesmerte
NO991734D0 (no) Pyrazolinoner for behandling av potensforstyrrelser
NO20003481D0 (no) FremgangsmÕte for behandling av COPD
NO991158L (no) FremgangsmÕte for behandling av amyotrofisk lateralsklerose
NO984189D0 (no) Fremgangsmåte for behandling av bipolar forstyrrelse
NO982562D0 (no) Sammensetning for behandling av smerte
NO993549D0 (no) Imino-aza-antracyklinonderivater til behandling av amyloidosis
NO986053D0 (no) Antikonvulsive derivater for behandling av psoriasis
NO962812D0 (no) Fremgangsmåte for behandling av nervebetennelse
DK0737068T3 (da) 2,3-diaryl-1-benzopyraner til behandling af dermatitis
SI0928183T1 (en) Use of 1-hydroxy-2-pyridone for the treatment of seborrheic dermatitis
NO20011268D0 (no) Forbindelse til behandling av depresjon
NO984190D0 (no) Fremgangsmåte for behandling av insomnia
NO996166D0 (no) Fremgangsmåte for behandling av avluter
FI944868A0 (fi) Foerfarande foer foerbaettring av en braennare
FI943862A0 (fi) Foerfarande foer framstaellning av en kretsmoensterfolie

Legal Events

Date Code Title Description
MK1K Patent expired